2025-09-04 - Analysis Report
Okay, here's an analysis of Colgate-Palmolive (CL) based on the provided data. The report is structured with key figures first, followed by interpretations and a final summary.

## Colgate-Palmolive Co (CL) Stock Analysis

**Company Overview:** Colgate-Palmolive Co is a global consumer products company specializing in the production, distribution, and provision of household, health care, and personal care products.

### 1. Performance vs. S&P 500 (VOO)

*   **CL Cumulative Return:** 10.67%
*   **VOO Cumulative Return:** 99.17%
*   **Absolute Divergence:** -91.8%
*   **Divergence Range:** Max: 7.9%, Min: -91.8%
*   **Relative Divergence:** 0.0

**Analysis:** CL has significantly underperformed the S&P 500 (VOO) over the given period. The relative divergence of 0.0 indicates that the current underperformance is at the lowest end of its historical range compared to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD      | Alpha   | Beta | Cap(B) |
|------------|---------|----------|---------|------|--------|
| 2015-2017  | 13.0%   | 4.5%     | -16.0%  | 0.0  | 61.0   |
| 2016-2018  | -11.0%  | 65.2%    | -29.0%  | 0.1  | 48.1   |
| 2017-2019  | 7.0%    | 65.2%    | -22.0%  | 0.1  | 55.6   |
| 2018-2020  | 18.0%   | 65.2%    | -2.0%   | 0.6  | 69.1   |
| 2019-2021  | 30.0%   | 58.6%    | -19.0%  | 0.7  | 69.0   |
| 2020-2022  | 7.0%    | 69.0%    | 5.0%    | 0.7  | 63.7   |
| 2021-2023  | 6.0%    | 69.0%    | -12.0%  | 0.8  | 64.4   |
| 2022-2024  | 13.0%   | 69.0%    | -12.0%  | 0.8  | 73.5   |
| 2023-2025  | -3.0%   | 70.6%    | -54.0%  | 0.3  | 67.4   |

**Analysis:**

*   **CAGR:**  The Compound Annual Growth Rate fluctuates significantly over the different periods, indicating varying performance.
*   **MDD:** The Maximum Drawdown is high in several periods, suggesting substantial risk.
*   **Alpha:**  Mostly negative Alpha indicates underperformance relative to the market.  The period 2020-2022 showed positive Alpha, suggesting a period of relative outperformance.
*   **Beta:**  Beta values are generally low, suggesting lower volatility compared to the market.

### 2. Recent Price Action

*   **Current Price:** 83.42
*   **Last Market Data:** Price: 83.44, Previous Close: 84.39, Change: -1.13
*   **5-Day Moving Average:** 83.9
*   **20-Day Moving Average:** 84.72
*   **60-Day Moving Average:** 87.56

**Analysis:** The current price is below all moving averages, indicating a short-term downtrend. The recent change of -1.13, while not extreme, contributes to the overall bearish signal. The stock price has been gradually decreasing.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.34 (Low Risk)
*   **RSI:** 43.11 (Neutral, but trending towards oversold)
*   **PPO:** -0.0295 (Negative, indicating a downtrend)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (1209 shares - Safe (OverSold Boost) - MRI:0.32)
*   **20-Day Relative Divergence Change:** -3.3 (Negative, indicating short-term decline)
*   **Expected Return:** -3663.3%

**Analysis:**

*   The MRI suggests a low-risk environment, but the RSI and PPO point towards a potential oversold condition and continued downtrend.
*   The Hybrid Signal recommends buying, potentially based on the oversold condition (Boost).
*   The significant negative expected return is a major concern.  This suggests a long-term pessimistic outlook relative to the S&P 500.  This number is unusually large and warrants further investigation.

### 4. Recent News & Significant Events

*   **2025-09-02:** Major business developments, regulatory changes, or market events impacting CL.
*   **2025-08-31:** Analysts discussing CL's performance and outlook.
*   **2025-09-01:** Notable stock volatility influenced by recent news, earnings, or executive actions.
*   **2025-09-03:** Market experts highlight both risks and opportunities, advising monitoring news and announcements.

**Analysis:** Recent news suggests potential volatility and significant events influencing the stock. Investors should closely monitor news and announcements for any new updates.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue  |
|------------|------|----------|
| 2025-08-01 | 0.92 | 5.11 B$  |
| 2025-04-25 | 0.85 | 4.91 B$  |
| 2024-10-25 | 0.9  | 5.03 B$  |
| 2024-07-26 | 0.89 | 5.06 B$  |
| 2025-08-01 | 0.89 | 5.06 B$  |

**Analysis:**  The EPS and Revenue figures show a relatively stable performance. Revenue is hovering around $5 billion, and EPS is around $0.90. There is a slight improvement in the most recent quarter.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-06-30 | $5.11B     | 60.06%        |
| 2025-03-31 | $4.91B     | 60.82%        |
| 2024-12-31 | $4.95B     | 60.30%        |
| 2024-09-30 | $5.03B     | 61.08%        |
| 2024-06-30 | $5.06B     | 60.62%        |

**Capital and Profitability:**

| Quarter    | Equity     | ROE       |
|------------|------------|-----------|
| 2025-06-30 | $0.70B     | 105.84%   |
| 2025-03-31 | $0.36B     | 190.08%   |
| 2024-12-31 | $0.21B     | 348.58%   |
| 2024-09-30 | $0.43B     | 169.43%   |
| 2024-06-30 | $0.12B     | 594.31%   |

**Analysis:**

*   **Revenue and Profitability:** Revenue is consistent, and the profit margin is impressively high and stable, indicating strong operational efficiency.
*   **Capital and Profitability:**  Equity fluctuates, but the Return on Equity (ROE) is extremely high, suggesting efficient use of equity to generate profits. However, the relatively low Equity value compared to Revenue suggests a leveraged financial structure, which could amplify both gains and losses.

### 7. Overall Analysis and Summary

Colgate-Palmolive (CL) presents a mixed picture. While the company exhibits strong profitability with high profit margins and ROE, it has significantly underperformed the S&P 500. Recent price action indicates a short-term downtrend, and while the MRI suggests low overall market risk, other technical indicators like RSI and PPO suggest potential oversold conditions but continued downward momentum.

The recent news indicates potential volatility and significant events influencing the stock. The extremely negative expected return is a major cause for concern and requires further investigation. While stable EPS and revenue demonstrate the company's fundamental strength, the underperformance relative to the market and the negative expected return raise red flags.

**In summary:**

*   **Strengths:** High profit margins, high ROE, relatively stable earnings.
*   **Weaknesses:** Significant underperformance compared to S&P 500, recent downtrend, negative expected return, volatile news environment.

**Recommendation:** Given the conflicting signals, a cautious approach is warranted. Investors should closely monitor news, company announcements, and market trends before making any investment decisions. The negative expected return needs to be thoroughly investigated to understand the underlying factors driving this pessimistic outlook. It might be prudent to wait for more positive indicators before considering an investment in CL.
